Trading in Pitanium Limited is halted pending additional information from the company, following a prior SEC suspension.
Quiver AI Summary
On October 18, 2025, the Nasdaq Stock Market announced that trading in Pitanium Limited (PTNM) has been halted pending additional information requested from the company. This follows a recent trading suspension by the Securities and Exchange Commission, which lasted from October 6 to October 17, 2025. The last recorded price of PTNM shares was $10.39. Trading will remain suspended until Pitanium Limited complies with Nasdaq's request for further information. For updates about the company, stakeholders are encouraged to reach out directly or check Nasdaq's website.
Potential Positives
- e
Potential Negatives
- Trading in Pitanium Limited has been halted due to additional information requested by Nasdaq, indicating potential regulatory concerns or issues within the company.
- The company previously faced a trading suspension by the SEC, which could raise red flags for investors regarding its compliance and operational integrity.
- Ongoing trading halts may signal to the market a lack of transparency or potential financial instability, potentially impacting investor confidence.
FAQ
Why is trading halted for Pitanium Limited (PTNM)?
Trading is halted due to additional information requested by Nasdaq from Pitanium Limited.
When did the SEC suspend trading for PTNM?
The SEC suspended trading for PTNM from October 6 to October 17, 2025.
What was PTNM's last sale price before trading halted?
The last sale price of Pitanium Limited's ordinary shares was $10.39.
How can I find more information about the SEC's order?
More information can be found at the SEC's official website link provided in the press release.
Where can I get news about Pitanium Limited?
For news and information, contact the company directly or check their Nasdaq symbol using InfoQuotesSM.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$NDAQ Congressional Stock Trading
Members of Congress have traded $NDAQ stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NDAQ stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY purchased up to $50,000 on 09/19.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$NDAQ Insider Trading Activity
$NDAQ insiders have traded $NDAQ stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $NDAQ stock by insiders over the last 6 months:
- BRADLEY J PETERSON (EVP, CIO) sold 11,508 shares for an estimated $1,022,715
- MICHELLE LYNN DALY (SVP, Controller & PAO) sold 8,691 shares for an estimated $812,173
- JEREMY SKULE (EVP, CSO) has made 0 purchases and 5 sales selling 8,421 shares for an estimated $758,471.
- PC NELSON GRIGGS (Pres. Capital Access Platforms) has made 0 purchases and 2 sales selling 8,000 shares for an estimated $664,240.
- CHARLENE T BEGLEY sold 3,000 shares for an estimated $289,800
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NDAQ Hedge Fund Activity
We have seen 548 institutional investors add shares of $NDAQ stock to their portfolio, and 382 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- THOMA BRAVO, L.P. removed 42,804,207 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,827,552,189
- WELLINGTON MANAGEMENT GROUP LLP added 8,507,606 shares (+26.0%) to their portfolio in Q2 2025, for an estimated $760,750,128
- JANE STREET GROUP, LLC added 7,187,313 shares (+40335.1%) to their portfolio in Q2 2025, for an estimated $642,689,528
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 6,840,735 shares (+33.5%) to their portfolio in Q2 2025, for an estimated $611,698,523
- CAPITAL WORLD INVESTORS removed 6,628,258 shares (-97.8%) from their portfolio in Q2 2025, for an estimated $592,698,830
- VANGUARD GROUP INC added 2,820,339 shares (+5.3%) to their portfolio in Q2 2025, for an estimated $252,194,713
- NEUBERGER BERMAN GROUP LLC added 1,946,479 shares (+261.7%) to their portfolio in Q2 2025, for an estimated $174,054,152
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NDAQ Analyst Ratings
Wall Street analysts have issued reports on $NDAQ in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 07/25/2025
- Barclays issued a "Overweight" rating on 07/25/2025
- Deutsche Bank issued a "Buy" rating on 07/25/2025
- UBS issued a "Buy" rating on 07/25/2025
- RBC Capital issued a "Outperform" rating on 07/25/2025
- Piper Sandler issued a "Overweight" rating on 07/15/2025
- Raymond James issued a "Outperform" rating on 07/09/2025
To track analyst ratings and price targets for $NDAQ, check out Quiver Quantitative's $NDAQ forecast page.
$NDAQ Price Targets
Multiple analysts have issued price targets for $NDAQ recently. We have seen 10 analysts offer price targets for $NDAQ in the last 6 months, with a median target of $104.0.
Here are some recent targets:
- Patrick O'Shaughnessy from Raymond James set a target price of $100.0 on 10/13/2025
- Benjamin Budish from Barclays set a target price of $108.0 on 10/08/2025
- Michael Cyprys from Morgan Stanley set a target price of $90.0 on 10/01/2025
- Richard Repetto from Piper Sandler set a target price of $104.0 on 08/04/2025
- Ashish Sabadra from RBC Capital set a target price of $108.0 on 07/25/2025
- Brian Bedell from Deutsche Bank set a target price of $105.0 on 07/25/2025
- Kyle Voigt from Keefe, Bruyette & Woods set a target price of $104.0 on 07/25/2025
Full Release
NEW YORK, Oct. 18, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market ® (Nasdaq: NDAQ) announced that trading is halted in Pitanium Limited (Nasdaq: PTNM) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in PTNM from 04:00:00 on October 6, 2025 to 23:59:00 on October 17, 2025. The last sale price of the company’s ordinary shares was $10.39.
More information about the SEC’s order can be found at https://www.sec.gov/files/litigation/suspensions/2025/34-104165.pdf .
Trading will remain halted until Pitanium Limited has fully satisfied Nasdaq’s request for additional information.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotes SM on the Nasdaq ® Web site.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com .
Nasdaq Media Contact:
Michelle Mendiola
[email protected]
NDAQO
